Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.03 (+3.81%)
As of: Aug 21, 2026 · 3:59 PM EDT

Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025)

Cresco Labs' (CRLBF) quarterly Cash from Financing Activities came in at -$1.8 million in Q4 2025, up 95.73% YoY from -$916037.2 in Q4 2024, and up 97.48% on a QoQ basis from -$71.1 million in Q3 2025.

Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025) Analysis & Trends

Cresco Labs (CRLBF) has 7 years of Cash from Financing Activities data on file, last reported at -$1.8 million in Q4 2025.

  • Quarterly Cash from Financing Activities rose 95.73% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$117.4 million (down 207.07% YoY) and the FY2025 annual result came in at -$82.1 million, down 14.84% from the prior year.
  • Cash from Financing Activities advanced to -$1.8 million in Q4 2025, from -$71.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $132.2 million in Q1 2021 to a low of -$71.1 million in Q3 2025.
  • A 5-year average of $371486.6 and a median of -$3.1 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities soared 860.8% — and 2025, when it sank 2785.39%.
  • Tracing CRLBF's Cash from Financing Activities over 5 years: stood at -$2.4 million in 2021, then rose by 14.48% to -$2.0 million in 2022, then slumped by 86.21% to -$3.8 million in 2023, then sank by 1011.42% to -$42.0 million in 2024, then soared by 95.73% to -$1.8 million in 2025.
  • The last three Cash from Financing Activities figures came in at -$1.8 million (Q4 2025), -$71.1 million (Q3 2025), and -$42.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -1.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Cresco Labs 304.06 Mn 239.95 Mn 86.95 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.79 Mn
Dec 31, 2025 -1.79 Mn
Sep 30, 2025 -71.10 Mn
Sep 30, 2025 -71.10 Mn
Dec 31, 2024 -42.03 Mn
Dec 31, 2024 -42.03 Mn
Sep 30, 2024 -2.46 Mn
Sep 30, 2024 -2.46 Mn
Dec 31, 2023 -3.78 Mn
Dec 31, 2023 -3.78 Mn
Sep 30, 2023 10.05 Mn
Sep 30, 2023 10.05 Mn
Dec 31, 2022 -2.03 Mn
Dec 31, 2022 -2.03 Mn
Sep 30, 2022 -9.11 Mn
Sep 30, 2022 -9.11 Mn
Jun 30, 2022 -69.14 Mn
Jun 30, 2022 -69.14 Mn
Mar 31, 2022 -6.37 Mn
Mar 31, 2022 -6.37 Mn